Latest News & Updates

Breaking News

  • 8 hours ago

  • Pharma Now Editorial Team

MHRA Ramipril Batch Recall Puts Batch Release Controls Under Scrutiny
Breaking News
IPI201 Enters Phase I as Isosceles Clears First-Patient Dosing

Pharma Now Editorial Team

Other trending news you may like to read

MHRA Ramipril Batch Recall Puts Batch Release Controls Under Scrutiny

MHRA recalls a Ramipril batch over a manufacturing error, prompting QA directors to review batch release and deviation management controls.

Pharma Now Editorial Team

Pharma Now

IPI201 Enters Phase I as Isosceles Clears First-Patient Dosing

Isosceles Pharmaceuticals doses first patient in Phase I trial of IPI201, triggering CMC and manufacturing readiness obligations.

Pharma Now Editorial Team

Pharma Now

AI Antibody Alliances Signal New Pressure on Biologic CMOs

Galux and GC Biopharma partner on AI antibody discovery, raising upstream speed questions for GMP manufacturers and QA teams.

Pharma Now Editorial Team

Pharma Now

Asian Pharma Affairs Act Revisions Reshape Nonessential Drug Supply Rules

Proposed Pharmaceutical Affairs Act revisions would give government authority over nonessential drug supply under defined conditions. Comment period closes June 10.

Pharma Now Editorial Team

Pharma Now